Slide 1: INVO Center Review
@ INVO.~ INVO Center Review March 2022
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results o
Slide 3: Our Mission
(a) INVO bioscience Our Mission is
Slide 4: INVO Centers: fertility clinics delivering INVOcell
(2) INVO bioscience ¢ fertility clinics dedicated to delivering INVOcell and the IVC treatment, * aunique approach for delivering our innovative device technology; and * akey part of our commercialization strategy. 4 | INVO Bioscience _
Slide 5: INVO Centers Address Key Industry Challenges
INVO Centers Address Key Industry Challenges Treatment Costs * Relative high costs of IVF treatment reduces access for many Infrastructure and Capacity Constraints ¢ Limited number of IVF clinics - clustered in population centers, which also drives up costs for patients in rural areas * Clinic throu
Slide 6: INVO Centers: A Key Part of our Mission and Commercial Strategy
INVO Centers A Key Part of our Mission and Commercial Strategy Business Structure * Partner with physician operators to create dedicated INVO Centers « _INVO Bioscience to provide the device, funding, access to training, and technology/lab support and management * Partner responsible for medical dec
Slide 7: Our Year Goals 2022 thru 2024
Our 3 Year Goals 2022 thru 2024 20 Fully operational INVO Centers 12,000: Annual INVO Center cycles + Barely scratching the surface when considering: * Current annual U.S. IVF cycles = ~330,000 * Adding an incremental 12,000 INVO Center cycles is only a 3.6% increase for the industry - real market n
Slide 8: Site Selection Process
Site Selection Process Various factors, both quantitative and qualitative go into choosing potential locations Te Ee Insurance Health System Mandates Ownership Eliminating areas with Avoid markets where comprehensive insurance _a health system owns mandates both the OBGYN’s and fertility clinics 19
Slide 9: INVO Centers: North American Focus
INVO Centers: North American Focus We have expanded our initial city list to 27 potential locations and will plan to prioritize them to optimize the geography specifics and growth trajectory. 9 Operating INVO Centers 9 Announced Sites 9 Sites under active review* *Cities for which preliminary review
Slide 10: Building an INVO Center
Building an INVO Center Est 3-year operating P&L Estimated time, costs and initial operating targets it [ \ 1@) Step 1 1) Step 3 9 Step 5 Year 1 © Year 3 e e Site Selection Site Build Out and Begin Local e Op loss of © Profit of Equipment Setup Physician Referral @ ~$350K after @ ~$1.45M+ Program An
Slide 11: Per INVO Center: Year Plan
Per INVO Center: 3 Year Plan # of Procedure Cycles Average Revenue** Net Operating Income 706 per INVO Center 250001000 per INVO Center eiepo7000 per INVO Center ~$1,450,000 $4,500,000 $4,350,000 $1,400,000 600 582 $4,000,000 $1,200,000 1,000,000 500 $3,500,000 : $800,000 $3,000,000 400 $600,000 310
Slide 12: INVO Center Model Potential
INVO Center Model Potential Potential Annual Revenue from INVO Centers NP we Le Longer Term P could be significantly hid Potential Annual Operating Profit from INVO Centers franchise opportunities. 12 | INVO Bioscience 2) INVO bioscience